1. Vannier EG, Diuk-Wasser MA, Mamoun CB, Krause PJ. Babesiosis. Infect Dis Clin North Am 2015;29(2):357–370.
2. Babes V. Sur l’he’moglobinurie bacte´rienne du boeuf. CR Acad. Sci. 1888;107:692–694.
3. Starcovici C. 1893. Bemerkungen u¨ber den durch Babes entdeckten Blutparasiten und die durch denselben hervorgebrachten Krakheiten, die seuchenhafte Ha¨moglobinurie des Rindes
(Babes), dans Texasfieber (Th. Smith) und der Carceag der Schafe (Babes). Zbl. Bakt., I. Abt. 14, 1–8.
4. Vannier E, Krause PJ. Human babesiosis. New Engl J Med. 2012;366(25):2397–407.
5. Western KA, Benson GD, Gleason NN, Healy GR, Schultz MG. 1970. Babesiosis in a Massachusetts resident. N Engl J Med 283:854–856.
6. Beugnet F, Moreau Y. Babesiosis. Rev Sci Tech. 2015;34(2):627-39.
7. Yabsley MJ, Shock BC. 2013. Natural history of zoonotic Babesia: role of wildlife reservoirs. Int J Parasitol Parasites Wildl 2:18–31.
8. Leiby DA. Transfusion-transmitted Babesia spp. bull’s eye on Babesia microti. Clinical microbiology reviews 2011;24(1):14–28.
9. Lempereur L, Beck R, Fonseca I, Marques C, Duarte A, Santos M, et al. Guidelines for the Detection of Babesia and Theileria Parasites. Vector Borne Zoonotic Dis. 2017;17(1):51-65
10. Tanyüksel M, Duyan S. Babesia Türleri. Willke Topcu A, Söyletir G, Doğanay M, editörler. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. 4.baskı. İstanbul: Nobel Tıp Kitabevleri;2017 s:2200-2204
11. Chauvin A, Moreau E, Bonnet S, Plantard O, Malandrin L. Babesia and its hosts: adaptation to long-lasting interactions as a way to achieve efficient transmission. Vet Res. 2009;40(2):37.
12. Rożej-Bielicka W, Stypułkowska-Misiurewicz H, Gołąb E. Human babesiosis. Przegl Epidemiol. 2015;69(3):489-94, 605-8
13. Centers for Disease Control and Prevention, 2024. Erişim linki: https://www.cdc.gov/parasites/babesiosis/index.html ( Erişim tarihi: 27 Mart 2024)
14. Lippi CA, Ryan SJ, White AL, Gaff HD, Carlson CJ. “Trends and opportunities in tick-borne disease geography”. Journal of Medical Entomology. 2021;58(6):2021-2029.
15. Lukavská A, Kybicová K. Human babesiosis. Epidemiol Mikrobiol Imunol. 2023;72(3):184-190.
16. Elbadawi LI, Kazmierczak J, Davis JP. 2017. Babesiosis surveillance—Wisconsin, 2001–2015. MMWR Morb Mortal Wkly Rep 66: 687– 691.
17. Centers for Disease Control and Prevention. Annual tables of infectious disease data. Erişim linki: https:// wonder.cdc.gov/nndss/static/2016/annual/2016-table1.html. ( Erişim tarihi: 28 Mart
2024 ).
18. Herwaldt B, Persing DH, Precigout EA, Goff WL, Mathiesen DA, Taylor PW, et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern
Med 1996;124:643–650.
19. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med. 2011;155:509–19.
20. Gray EB, Herwaldt BL. Babesiosis surveillance – United States, 2011–2015. MMWR Surveill Summ 2019;68:1–11.
21. Hildebrandt A, Gray JS, Hunfeld KP. Human babesiosis in Europe: What clinicians need to know. Infection. 2013;41(6):1057–1072.
22. Madison-Antenucci S, Kramer LD, Gebhardt LL, Kauffman E. Emerging Tick-Borne Diseases. Clin Microbiol Rev. 2020;33(2):e00083-18.
23. Zhou X, Li SG, Chen SB, Wang JZ, Xu B, Zhou HJ, et al. Co-infections with Babesia microti and Plasmodium parasites along the China-Myanmar border. Infect Dis Poverty. 2013;2:24.
24. Sun Y, Li SG, Jiang JF, Wang X, Zhang Y, Wang H, et al. Babesia venatorum infection in child. China Emerg Infect Dis. 2014;20(5):896–7.
25. Jiang JF, Zheng YC, Jiang RR, Li H, Huo QB, Jiang BG, et al. Epidemiological, clinical, and laboratory characteristics of 48 cases of “Babesia venatorum” infection in China: a descriptive study.
Lancet Infect Dis. 2015;15(2):196–203.
26. Jia N, Zheng YC, Jiang JF, Jiang RR, Jiang BG, Wei R, et al. Human babesiosis caused by a Babesia crassa-like pathogen: a case series. Clin Infect Dis. 2018;67:1110–9.
27. Gören S, Yetkin R. (1935): Tektırnaklıda, sığırda, koyunda, keçide ve köpekte piroplasmoz. Ulus Basımevi, Ankara.
28. Kalkan K, Özçelik S, Malatyalı E. Sivas’ta insanlarda babesiozis seroprevalansının araştırılması. Cumhuriyet Tıp Dergisi. 2010;32(4):276-280
29. Poyraz Ö, Güneş T. Sinop Yöresinde Kırsal Kesimde Yaşayan İnsanlarda Babesia microti Seroprevalansı. Türkiye Parazitol Derg. 2010;34(2):81-85.
30. Tanyel E, Guler N, Hokelek M, Ulger F, Sunbul M. A case of severe babesiosis treated successfully with exchange transfusion. Int J Infect Dis. 2015;38:83-5.
31. Kepenek Kurt E, Kandemir B, Handemir E, Bitirgen M. Konya‘da nadir görülen zoonotik infeksiyon; babesiozis olgu sunumu. Genel Tıp Derg. 2021;31(2)182-184
32. Zimmer AJ, Simonsen KA. Babesiosis. 2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 28613466.
33. Krause PJ. Human babesiosis. Int J Parasitol. 2019;49(2):165–174.
34. Hemmer RM, Ferrick DA, Conrad PA. Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate
WA1. Parasitol Res. 2000;86:121–128.
35. White DJ, Talarico J, Chang HG, Birkhead GS, Heimberger T, Morse DL. Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern
Med. 1998;158:2149–2154.
36. Centers for Disease Control and Prevention, 2024. Erişim linki: https://www.cdc.gov/parasites/babesiosis/index.html ( Erişim tarihi: 27 Mart 2024)
37. Levin AE, Krause PJ. Transfusion-transmitted babesiosis: is it time to screen the blood supply? Curr Opin Hematol. 2016;23(6):573–580.
38. Mareedu N, Schotthoefer AM, Tompkins J, Hall MC, Fritsche TR, Frost HM. Risk factors for severe infection, hospitalization, and prolonged antimicrobial therapy in patients with babesiosis.
Am J Trop Med Hyg. 2017;97:1218–1225.
39. Zhou X, Li SG, Chen SB, Wang JZ, Xu B, Zhou HJ, et al. Co-infections with Babesia microti and Plasmodium parasites along the China-Myanmar border. Infect Dis Poverty. 2013;2:24.
40. Wang G, Villafuerte P, Zhuge J, Visintainer P, Wormser GP. Comparison of a quantitative PZR assay with peripheral blood smear examination for detection and quantitation of Babesia
microti infection in humans. Diagn Microbiol Infect Dis. 2015;82:109–13.
41. Jahfari S, Hofhuis A, Fonville M, van der Giessen J, van Pelt W, Sprong H. Molecular detection of tick-borne pathogens in humans with tick bites and erythema migrans, in the Netherlands.
PLoS Negl Trop Dis. 2016;10:e0005042.
42. Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, et al. Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol. 2002;40:2431–
2436.
43. Krause PJ, Ryan R, Telford S, Persin D, Spielman A. Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis. J Clin Microbiol. 1996;34(8):2014-6.
44. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020. Guideline on Diagnosis and Management of Babesiosis. Erişim linki: https://www.idsociety.org/
practice-guideline/babesiosis/ (Erişim tarihi: 2 Nisan 2024)
45. Bloch EM, Kumar S, Krause PJ. Persistence of Babesia microti infection in humans. Pathogens. 2019;8:102.